PREVENTION OF ACUTE AND CHRONIC LIVER-DISEASE THROUGH IMMUNIZATION - HEPATITIS-B AND BEYOND

被引:50
作者
MARGOLIS, HS
机构
[1] Hepatitis Branch (World Health Organization Collaborating Centre for Research and Reference in Viral Hepatitis), Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Atlanta
关键词
D O I
10.1093/infdis/168.1.9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver disease caused by hepatotrophic viruses imposes a substantial burden on health care resources. Persistent infections from hepatitis B virus (HBV), hepatitis C virus, and hepatitis delta virus result in chronic liver disease, while hepatitis A virus and hepatitis E virus produce a self-limited disease. Effective hepatitis B vaccines that provide long-term protection against chronic HBV infection have been available for > 10 years, while inactivated hepatitis A vaccines have recently been shown to prevent acute disease. To prevent transmission of HBV, scientifically and epidemiologically sound recommendations call for vaccination of all infants in successive birth cohorts worldwide. For hepatitis A vaccines, recommendations will be developed in the near future and should reflect vaccine performance and the epidemiology of hepatitis A. A number of policy, health care financing, and educational issues must be addressed to ensure the effective use of both of these vaccines.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 56 条
  • [1] THE CHANGING EPIDEMIOLOGY OF HEPATITIS-B IN THE UNITED-STATES - NEED FOR ALTERNATIVE VACCINATION STRATEGIES
    ALTER, MJ
    HADLER, SC
    MARGOLIS, HS
    ALEXANDER, WJ
    HU, PY
    JUDSON, FN
    MARES, A
    MILLER, JK
    MOYER, LA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (09): : 1218 - 1222
  • [2] SIMULTANEOUS VACCINATION AGAINST HEPATITIS-A AND HEPATITIS-B - RESULTS OF A CONTROLLED-STUDY
    AMBROSCH, F
    ANDRE, FE
    DELEM, A
    DHONDT, E
    JONAS, S
    KUNZ, C
    SAFARY, A
    WIEDERMANN, G
    [J]. VACCINE, 1992, 10 : S142 - S145
  • [3] ANDRE FE, 1990, PROG MED VIROL, V37, P72
  • [4] [Anonymous], 1991, MMWR Recomm Rep, V40, P1
  • [5] BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547
  • [6] BEASLEY RP, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P532
  • [7] HEPATITIS DELTA VIRUS - PROTEIN-COMPOSITION OF DELTA ANTIGEN AND ITS HEPATITIS-B VIRUS-DERIVED ENVELOPE
    BONINO, F
    HEERMANN, KH
    RIZZETTO, M
    GERLICH, WH
    [J]. JOURNAL OF VIROLOGY, 1986, 58 (03) : 945 - 950
  • [8] RECENT DEVELOPMENTS IN THE MOLECULAR-CLONING AND CHARACTERIZATION OF HEPATITIS-C AND HEPATITIS-E VIRUSES
    BRADLEY, DW
    BEACH, MJ
    PURDY, MA
    [J]. MICROBIAL PATHOGENESIS, 1992, 12 (06) : 391 - 398
  • [9] CHEN DS, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P716
  • [10] THE GAMBIA HEPATITIS INTERVENTION STUDY - FOLLOW-UP OF A COHORT OF CHILDREN VACCINATED AGAINST HEPATITIS-B
    CHOTARD, J
    INSKIP, HM
    HALL, AJ
    LOIK, F
    MENDY, M
    WHITTLE, H
    GEORGE, MO
    LOWE, Y
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) : 764 - 768